Andrew Hessel, Genomic Futurist

Andrew Hessel is a futurist and catalyst in biological technologies, helping industry, academics, and authorities better understand the changes ahead in life science. He is a Distinguished Researcher with Autodesk Inc.’s Bio/Nano Programmable Matter group, based out of San Francisco. He is also the co-founder of the Pink Army Cooperative, the world’s first cooperative biotechnology company, which is aiming to make open source viral therapies for cancer.

Trained in microbiology and genetics, Andrew has continually worked at the forefront of genomics, first to read and comprehend bacterial, human, and other genomes and more recently to write them. He believes the technology that makes this possible, called synthetic biology, is revolutionary and that it will eventually surpass information technology (IT) as an economic engine and driver of societal change. He speaks widely on topics that include cells as living computers, life science as an emerging IT industry, and biological safety and security.

More Posts:

Evolution Of GM's EN-V Urban Electric Vehicle Concepts (Chevy En-V)
Green Minibus
Virtual Reality Gaming Comes Back With Oculus Rift Headset (+VIDEO)
ESA Will Build A Lunar Base Using A 3D Printer
Three-wheeled Toyota i-Road EV Ensures Freedom Of Mobility
BRAIN Initiative Challenges Researchers to Unlock Mysteries of Human Mind (Video and Infographi...
A New Design Of Ion Engines Leads To More Efficient Drives For Space Missions
Lamborghini Unveils The Most Exclusive Supercar Egoista (+VIDEO)
Infiniti Concept Vision Gran Turismo
Engineering Viruses To Produce Enhanced Photoelectrics